McGill IBD logo
Donate

Dr. Waqqas Afif


If you are interested in learning more about any of the clinical and research studies below or would like to volunteer as a research subject, please email: miirecherche.ibdresearch@muhc.mcgill.ca.

Collaboration with Dr. Greg Rosenfeld, University of British Columbia

Study Title: Pro-Active Fecal Calprotectin Monitoring to Improve Patient Outcomes in Ulcerative Colitis: A Prospective Randomized Control Trial (PROMOTE-UC)


Study Title: Pilot study to assess de-escalation of ustekinumab therapy in patients with Crohn’s disease


Study Title: Therapeutic drug monitoring guided early optimization of Adalimumab in Crohn’s disease. A randomized open-label study


Collaboration with Dr. Sasha Bernatsky, Research Institute of the McGill University Health Centre

Sponsor: Canadian Institutes of Health Research (CIHR)

Study Title: Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs


Study Title: A pilot study assessing performance of point-of-care testing for infliximab, adalimumab, C-reactive protein, and fecal calprotectin in inflammatory bowel disease patients with a secondary loss of response

Dr. Talat Bessisow


If you are interested in learning more about any of the clinical and research studies below or would like to volunteer as a research subject, please email: miirecherche.ibdresearch@muhc.mcgill.ca.

Study Title: Correlation between serum drug level and endoscopic mucosal healing in patients with inflammatory bowel disease treated with Vedolizumab and Ustekinumab


Study Title: Quantification and Effects of Ustekinumab on the tissues of the colon.


In collaboration with Dr. Sanjay Murthy, MD, MSc, FRCPC, University of Ottawa, The Ottawa Hospital – General Campus

Study Title: A Randomized Controlled Non-Inferiority Trial Comparing Neoplasia Detection During Colonoscopy Screening With and Without Non-Targeted Biopsies in Adult Colonic Inflammatory Bowel Disease


Sponsor : University Hospital Leuven, Herestraat 49, 3000 Leuven

Study Title: PRognOstiC valuE of rEd Density in Ulcerative Colitis: PROCEED-UC STUDY Predictive value of new endoscopic technique in ulcerative colitis


In collaboration with Collaboration with Hamilton Health Sciences/Dr. Neeraj Narula

Study Title: Tofacitinib for hospitalized acute severe Ulcerative colitis Management
(the TRIUMPH study)


Collaboration with Dr. Saji George, Ph.D., Associate Professor, Canada Research Chair in Sustainable Nanotechnology for Food and Agriculture

Study Title: Effect of dietary nanomaterials on the development and disease progression of inflammatory bowel disease


Collaboration with Dr. Bruce Mazer

Study Title: CTTB Biobank and Registry MANAGEMENT FRAMEWORK

Dr. Alain Bitton


If you are interested in learning more about any of the clinical and research studies below or would like to volunteer as a research subject, please email: miirecherche.ibdresearch@muhc.mcgill.ca.

Sponsor: Dr. Paul Moayyedi, McMaster University
Funding: Canadian Institutes of Health Research (CIHR)

Study Title: Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects: the IMAGINE-SPOR chronic disease network


The following 4 studies are part of NIH-NIDDK IBD Genetics Consortium (IBDGC)

  1. Identifying genes responsible for inflammatory bowel disease
  2. Mechanisms of microbiota in mucosal inflammation across the biologic demarcation of Ulcerative Colitis
  3. Mechanisms of intestinal inflammation following ileal resection for Crohn’s Disease
  4. Understanding the Genetics of Inflammatory Bowel Disease: The Diversity Study

Sponsor: Dr. John D. Rioux, Montreal Heart Institute
Funding:  Génome Canada (Rioux), National Institutes of Health (Rioux) and Pfizer Canada Inc. (Rioux)
Study Title: iGenoMed – CHUM: Identification of biomarkers of response to molecularly-targeted therapies in inflammatory bowel diseases


Study Title: Natural History of IBD in Quebec (as part of an initiative by the Canadian Gastro-Intestinal Epidemiology Consortium)

Dr. Alain Bitton & Dr. Terry Sigman


If you are interested in learning more about any of the clinical and research studies below or would like to volunteer as a research subject, please email: miirecherche.ibdresearch@muhc.mcgill.ca.

Sponsor: Dr. Kenneth Croitoru, Mount Sinai Hospital, Toronto ON with funding from Crohn’s and Colitis Canada

Study Title: A Multidisciplinary Human Study on the Genetic, Environmental and Microbial Interactions that Cause IBD (GEM Project)

Dr. Peter Lakatos


If you are interested in learning more about any of the clinical and research studies below or would like to volunteer as a research subject, please email Rita Kohen: rita.kohen@muhc.mcgill.ca

Study Title: Quality of Care Assessment of the MUHC IBD Center: Retrospective and Prospective Assessment of Quality or Care and Outcome Parameters before and after Installation of the IBD Center


 

Your donations help deliver specialized and quality care to people with inflammatory bowel disease (IBD) in Quebec.

Your generosity benefits the IBD clinics at the Montreal General Hospital, the Montreal Children's Hospital and the Jewish General Hospital.

Donate